Evaluation of temefos and pyriproxyfen to control Aedes aegypti larvae in laboratory conditions
DOI:
https://doi.org/10.24265/horizmed.2017.v17n4.05Keywords:
Dengue, Aedes, Temefos, PyriproxyfenAbstract
Objective: To evaluate the efficacy of temefos versus pyriproxyfen at different doses (0.01, 0.02, 0.03, 0.04 and 0.05 ppb) to control Aedes aegypti larvae in laboratory conditions. Materials and methods: An experimental study with control group which included 2,000 Aedes aegypti larvae from the Collique III Zona jurisdiction in Comas, Peru, and the Rockefeller strain as susceptible control. The difference in the time of onset of the larvicidal effect was established. Additionally, the survival and mortality rates with temefos versus pyriproxyfen were evaluated at different doses (0.01, 0.02, 0.03, 0.04 and 0.05 ppb) in laboratory conditions using the methodology recommended by the World Health Organization (WHO). Results: Based on the results, the Collique III Zona strain larvae exposed to temefos showed an average mortality rate of 68.4%, as opposed to the average mortality rate in the pyriproxyfen assay, which was 0.8%. Regarding the Rockefeller strain exposed to temefos, the average mortality rate was 100%, as opposed to the average mortality rate in the pyriproxyfen assay, which was 0.8%. This indicates that temefos has a faster larvicidal effect to control Aedes aegypti larvae. Conclusions: The Aedes aegypti larvae population was susceptible to insecticide temefos. A single application of temefos at 0.04 ppm showed a mortality rate of 92% in the larvae. With insect growth regulator pyriproxyfen, very low mortality rates were found in the Collique and Rockefeller strains.
Downloads
References
Molina de Fernández D, Bastidas D, Figueroa L. Malation vs. Aedes aegypti (Linnaeus, Diptera: Culicidae) de diferentes regiones de Venezuela, Boletín de Malariología y Salud Ambiental. 2013; 53(1): 46-55.
Ferreira M, dos Santos L, de Melo C, Pereira J, Gonzalez N. Perfil de susceptibilidad a Temefos en poblaciones de Aedes aegypti (Diptera: Culicidae) de Ciudad del Este - Alto Paraná, Paraguay Mem, Inst, Investig, Cienc. Salud, 2016;14(2): 98-105.
Gonzalez G, Resistencia a Insecticidas en el mosquito vector del dengue Aedes Aegypti (L) en sus epocas de transmisión de la enfermedad en Mérida, Yucatán [tesis doctoral], Mexico: Facultad de Ciencias Biológicas , Universidad Autónoma de Nuevo León; 2013.
Fernández-Salas I. Biología y Control de Aedes aegypti. Manual de Operaciones.Editorial UANL. Monterrey, México. 1999.
Mesa A, Alvarado G, Licona N, Ramos Raguilar M. Residualidad del Temefos en depósitos domésticos y su efectividad en el control de larvas de Aedes aegypti en Honduras, MEDISAN. 2013; 17(6):934-43
Palma H, Cabrera R, MoscosoM. Factores detrás de la renuencia al control vectorial del dengue en tres distritos del norte del Perú. Rev Peru Med Exp Salud Publica. 2016;33(1):13-20.
Rodriguez M, Bisset J, Fernandez Ditter, Perez O. Resistencia a insecticidas en larvas y adultos de Aedes aegypti: prevalencia de la esterasa A4 asociada con la resistencia a temefos, Rev Cubana Med Trop. 2004;56(1):54-60.
Cabezas C, Fiestas V, García-Mendoza M, Palomino M, Mamani E, Donaires F.Dengue en el Perú:a un cuarto de siglo de su reemergencia. Rev. Perú Med Exp Salud Publica.2015;32(1):146-56.
Rodríguez M, Terán M, Lazcano J, Leyva Y, Pacheco L, López Eficacia de Pyriproxyfeno en cepas de referencia de Aedes aegypti suceptible y resistente a temefos. Revista cubana de Medicina Tropical. 2014;65(3):339-49.
Palomino M, Solari L, León W, Vega R, Vergaray M, Cubillas L.Evaluación del efecto residual del temephos en larvas de Aedes Aegypti.Rev Perú Med Exp Salud Pública. 2006; 23(3): 158-62
Maestre R, Rey G, Salas J, VergaraC, Santacoloma L, Goenaga S, et al. Estado de suceptibilidad de Aedes aegypti a insecticidas en Atlántico (Colombia). Revista Colombiana de Entomología. 2010;36(2);242-8
Griñan L. Protocolo para pruebas de Laboratorio y composicion larvicidas de mosquitos. Tecnologia Quimica y Comercio SA.
World Health Organization. Guidelines for Laboratory and Field Testing of Mosquito Larvicides. Document. Switzerland: World Health Organization; 2005.
Organización Mundial de la Salud. Instructions for determining the susceptibility or resistance of mosquito larvae to insecticides. Geneva: WHO; 1981. p. 6
Camargo S. Organization and administration of Aedesaegypti control and eradication programmes. Bull World Health Organ. 1967; 36(4): 610-3.
Rodríguez R. Estrategias para el control del dengue y del Aedes aegypti en las Américas. Rev Cubana MedTrop. 2002; 54(3): 189-201.
Reiner E. Spontaneous reactivation of phosphorylated and carbamylated cholinesterases. Bull World Health Organ. 1971; 44(1-2-3): 109-12.
Sharma S, Saxena V, La I. Study on susceptibility status in aquatic and adult stages of Aedes aegypti and Aedes albopictus against insecticides at international airports of South India. J Commun Dis. 2004; 36(3):177-81.
Chávez J, Córdova O, Vargas F. Niveles de susceptibilidad a temephos en el vector transmisor del dengue en Trujillo, Perú, Anales de la Facultad de Medicina Universidad Nacional Mayor de San Marcos. 2005; 66(1):53-6
Published
How to Cite
Issue
Section
License
Copyright (c) 2017 Horizonte Médico (Lima)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Horizonte Médico (Lima) (Horiz. Med.) journal’s research outputs are published free of charge and are freely available to download under the open access model, aimed at disseminating works and experiences developed in biomedical and public health areas, both nationally and internationally, and promoting research in the different fields of human medicine. All manuscripts accepted and published in the journal are distributed free of charge under the terms of a Creative Commons license – Attribution 4.0 International (CC BY 4.0).
